Anand Rathi Share and Brokerage Ltd and Gujarat Kidney and Super Speciality Ltd have filed the Draft Red Herring Prospectus (DRHP) with the market regulator, Securities and Exchange Board of India.
While Anand Rathi Share and Brokerage is looking to raise Rs 745 crore via a fresh issue, the Gujarat Kidney and Super Speciality is offering 2.2 crore equity shares in a fresh issue.
Gujarat Kidney and Super Speciality
Gujarat Kidney and Super Speciality Limited had filed its Draft Red Herring Prospectus (DRHP) with the markets regulator, Securities and Exchange Board of India (SEBI), to raise capital via Initial Public Offering (IPO). The company’s IPO will offer a fresh issue of up to 2.2 crore Equity Shares, with a face value of Rs 2.
Gujarat Kidney and Super Speciality is a hospital chain that specialises in the field of urology. As of March 20, 2025, the company operates six multispeciality hospitals and three pharmacies within its Hospitals.
Anand Rathi Share and Stock Brokers
Anand Rathi Share and Stock Brokers, an arm of Anand Rathi Group, refiled its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for its Rs 745 crore Initial Public Offering (IPO).
Earlier, the company had filed its DRHP in December 2024. The IPO is entirely a fresh issue of shares up to Rs 745 crore and has a face value of Rs 5 per share.
Anand Rathi Share and Stock Brokers provides financial services, including broking, margin trading, and distribution of financial products, under the brand name ‘Anand Rathi.’. The company caters to a diverse clientele, including retail investors, high-net-worth individuals (HNIs), ultra-HNIs, and institutional clients.